289 related articles for article (PubMed ID: 26626643)
21. Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression.
Yu Y; Chen Q; Zhang X; Yang J; Lin K; Ji C; Xu A; Yang L; Miao L
Cancer Sci; 2020 Jul; 111(7):2297-2309. PubMed ID: 32378752
[TBL] [Abstract][Full Text] [Related]
22. TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma.
Ning S; Guo S; Xie J; Xu Y; Lu X; Chen Y
J Gastrointest Surg; 2013 Feb; 17(2):360-8. PubMed ID: 23207686
[TBL] [Abstract][Full Text] [Related]
23. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
[TBL] [Abstract][Full Text] [Related]
24. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
Zhou Z; Ma J
Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
[TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma.
Lu X; Zhou C; Li R; Deng Y; Zhao L; Zhai W
Cell Physiol Biochem; 2017; 42(1):222-230. PubMed ID: 28535506
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q
Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158
[TBL] [Abstract][Full Text] [Related]
27. Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma.
Sribenja S; Sawanyawisuth K; Kraiklang R; Wongkham C; Vaeteewoottacharn K; Obchoei S; Yao Q; Wongkham S; Chen C
BMC Cancer; 2013 Sep; 13():430. PubMed ID: 24053380
[TBL] [Abstract][Full Text] [Related]
28. Large numbers of interleukins-22- and -17A-producing T helper cells in cholangiocarcinoma related to liver fluke infection.
Su SB; Zhang JF; Huang FF; Cen Y; Jiang HX
Microbiol Immunol; 2017 Aug; 61(8):345-354. PubMed ID: 28718957
[TBL] [Abstract][Full Text] [Related]
29. Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.
Huang CK; Aihara A; Iwagami Y; Yu T; Carlson R; Koga H; Kim M; Zou J; Casulli S; Wands JR
Cancer Lett; 2016 Sep; 380(1):153-62. PubMed ID: 27364974
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma.
Junking M; Wongkham C; Sripa B; Sawanyawisuth K; Araki N; Wongkham S
Eur J Cancer; 2008 Mar; 44(4):619-26. PubMed ID: 18272359
[TBL] [Abstract][Full Text] [Related]
31. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
[TBL] [Abstract][Full Text] [Related]
32. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
[TBL] [Abstract][Full Text] [Related]
33. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
[TBL] [Abstract][Full Text] [Related]
34. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
[TBL] [Abstract][Full Text] [Related]
35. CpG-island methylation study of liver fluke-related cholangiocarcinoma.
Sriraksa R; Zeller C; El-Bahrawy MA; Dai W; Daduang J; Jearanaikoon P; Chau-In S; Brown R; Limpaiboon T
Br J Cancer; 2011 Apr; 104(8):1313-8. PubMed ID: 21448164
[TBL] [Abstract][Full Text] [Related]
36. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362
[TBL] [Abstract][Full Text] [Related]
37. Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma.
Tan XY; Chang S; Liu W; Tang HH
Gut Liver; 2014 Mar; 8(2):196-204. PubMed ID: 24672662
[TBL] [Abstract][Full Text] [Related]
38. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
[TBL] [Abstract][Full Text] [Related]
39. Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma.
Thanasai J; Limpaiboon T; Jearanaikoon P; Bhudhisawasdi V; Khuntikeo N; Sripa B; Miwa M
World J Gastroenterol; 2006 Jul; 12(27):4338-44. PubMed ID: 16865775
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
Liu B; Hu Y; Qin L; Peng XB; Huang YX
Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
